Loading candles…
Balaji Amines Ltd, incorporated in 1988 and headquartered in Solapur, Maharashtra, India, operates in the chemical, pharmaceutical, and agrochemical industries. The company specializes in manufacturing methylamines, ethylamines, derivatives of specialty chemicals, and pharma excipients. It also produces downstream derivatives used notably in pharmaceutical and pesticide sectors. Recognized as one of the largest producers of aliphatic amines in India, Balaji Amines has contributed to the development of indigenous manufacturing technologies aimed at reducing import dependency. Its operations are focused primarily within India.
This page is a live market overview for BALAJI AMINES LIMITED (BALAMINES) on the NSE. As a listed security, BALAJI AMINES LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BALAMINES before placing trades on tick2trade.
As of the latest feed, BALAMINES last traded at ₹2,029.6 on NSE, down ₹71.2 (3.39%) from the previous close of ₹2,100.8. Today's session range is ₹2,022.8 – ₹2,109, against a 52-week band of ₹968.1 – ₹2,443.6. Traded volume today stands at 1.11L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for BALAMINES in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BALAMINES is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BALAJI AMINES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BALAMINES. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BALAMINES option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | Balaji Amines Limited has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/ 2026 inter alia, to consider and appr… | 27 Jul 2026 |
| Audited Results - Q4 & FY26 | Balaji Amines Ltd-has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve … | 13 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 29 Jan 2026 |
| Unaudited Results - Q2 & FY25 | Balaji Amines Limited has informed NSE that meeting of the Board of Director of the Company is scheduled on 10/11/2025 inter alia, to consider and approve th… | 10 Nov 2025 |
| Results - FY25 | To consider and approve the Financial Results for the period ended Jun 30, 2025 | 2 Aug 2025 |
| Results - FY25 | BALAMINES : 28-May-2025 : The Company has informed the Exchange that a Board meeting to be held on May 26, 2025 has been re-scheduled. Further, the Company … | 28 May 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 26 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.